Loading
epidemiology
No description yet: the sentence for this tag has not been written. 11 records carry it: 10 people, 1 term.
Related tags
11 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Carla van Gils Bestuurder (Executive Director) of KWF Kankerbestrijding, jointly with Dorine Manson · KWF Dutch Cancer Society Cancer epidemiologist who co-leads KWF, the Dutch Cancer Society, the Netherlands' largest charitable funder of cancer research. | none | none | leadership, clinician-scientist, research-funding | ||
Counting the people who live after cancer, and why the number is not a detail The United States counts its cancer survivors each year and publishes the figure: 18.6 million in May 2025, projected to reach 22.4 million by 2035. Europe cannot produce an equivalent number, and that is a service-planning problem rather than a statistical one. | none | none | rejuvenation, survivorship, history | ||
Harry J. de Koning Professor of Public Health and Screening Evaluation, Erasmus MC · Erasmus MC Cancer Institute Led the NELSON trial, which confirmed CT screening cuts lung cancer deaths in Europe and shaped screening policy. | Non-small-cell lung cancer, Prostate cancer | none | screening, lung | ||
Jack Cuzick Professor of Epidemiology, Wolfson Institute of Population Health, Queen Mary University of London · Barts Cancer Institute / Barts Health NHS Trust Epidemiologist who led IBIS-I and IBIS-II, proving tamoxifen and anastrozole prevent breast cancer in high-risk women. | HR-positive / HER2-negative breast cancer, Cervical cancer | none | prevention, breast | ||
Katharina Staehelin Director, National Agency for Cancer Registration (NKRS), Zurich · National Agency for Cancer Registration (NKRS) / NICER She directs the Swiss office that turns the cantonal cancer registries' data into national figures, and is senior author of its national studies of prostate cancer and of cancer during the COVID-19 pandemic. | Prostate cancer, Colorectal cancer | none | registry | ||
Mark Schiffman Senior Investigator, Division of Cancer Epidemiology and Genetics, National Cancer Institute · National Cancer Institute (NIH) NCI epidemiologist whose HPV natural history studies underpin HPV-based cervical screening and risk-based management worldwide. | Cervical cancer | none | hpv, screening | ||
Michael Bretthauer Professor of Medicine, University of Oslo; Gastroenterologist, Oslo University Hospital · Oslo University Hospital, The Norwegian Radium Hospital Led NordICC, the first randomised trial of screening colonoscopy, which found smaller benefits than many expected. | Colorectal cancer | none | screening, colorectal | ||
Nubia Muñoz Emeritus Professor, National Cancer Institute of Colombia; former Chief of Field and Intervention Studies, IARC · Instituto Nacional de Cancerología (Colombia) Colombian epidemiologist whose IARC studies proved HPV causes cervical cancer and identified the types the vaccines target. | Cervical cancer | none | hpv, prevention, latin-america | ||
Rachel Ramoni Director, Division of Research · Kaiser Permanente Division of Research Director of the Kaiser Permanente Division of Research, one of the largest health-system research units in the United States. | none | none | leadership, health services research | ||
Sigurdur Y. Kristinsson Professor of Hematology, University of Iceland; Landspitali University Hospital · Landspítali, the National University Hospital of Iceland Leads iStopMM, which screened most of Iceland's adults for myeloma precursors to test whether early detection helps. | Multiple myeloma | none | myeloma, screening | ||
Sir Richard Peto Professor of Medical Statistics and Epidemiology, University of Oxford · Oxford Cancer (Oxford University Hospitals and University of Oxford) Epidemiologist who quantified how smoking kills and invented the meta-analysis methods that established adjuvant cancer therapy. | Non-small-cell lung cancer, HR-positive / HER2-negative breast cancer | none | tobacco, meta-analysis |
